$ODYS
Odysight.ai Inc. Stock $odys

$odys Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000149315223015723 Filed on May 08, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$674.0K	$303.0K	$2.000K
YoY Change	82.16%	15050.0%	-91.67%
Cost Of Revenue	$777.0K	$550.0K	$288.0K
YoY Change	38.5%	90.97%	41.87%
Gross Profit	-$103.0K	-$247.0K	-$286.0K
YoY Change	-46.07%	-13.64%	59.78%
Gross Profit Margin	-15.28%	-81.52%	-14300.0%
Selling, General & Admin	$1.661M	$1.134M	$1.529M
YoY Change	21.33%	-25.83%	41.84%
% of Gross Profit
Research & Development	$1.355M	$1.398M	$954.0K
YoY Change	32.71%	46.54%	186.49%
% of Gross Profit
Depreciation & Amortization	$37.00K	$155.0K	$50.00K
YoY Change	-30.19%	210.0%	194.12%
% of Gross Profit
Operating Expenses	$3.016M	$2.532M	$2.475M
YoY Change	26.19%	2.3%	75.41%
Operating Profit	-$3.119M	-$2.779M	-$2.761M
YoY Change	20.84%	0.65%	73.65%
Interest Expense	$240.0K	$86.00K	-$27.00K
YoY Change	-221.21%	-418.52%	68.75%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$2.876M	-$2.686M	-$2.788M
YoY Change	3.75%	-3.66%	73.6%
Income Tax
% Of Pretax Income
Net Earnings	-$2.876M	-$2.686M	-$2.788M
YoY Change	3.75%	-3.66%	73.6%
Net Earnings / Revenue	-426.71%	-886.47%	-139400.0%
Basic Earnings Per Share	-$0.28	-$0.37	-$0.39
Diluted Earnings Per Share	-$0.28	-$0.37	-$391.5K
COMMON SHARES
Basic Shares Outstanding	10.43M shares	10.43M shares	7.122M shares
Diluted Shares Outstanding	10.44M shares	7.276K shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$22.06M	$24.59M	$19.32M
YoY Change	30.89%	27.28%	51.5%
Cash & Equivalents	$3.319M	$9.583M	$8.292M
Short-Term Investments	$18.74M	$15.01M	$11.03M
Other Short-Term Assets	$668.0K	$564.0K	$416.0K
YoY Change	62.93%	35.58%	-8.17%
Inventory	$724.0K	$693.0K	$190.0K
Prepaid Expenses
Receivables	$158.0K	$61.00K	$14.00K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$23.61M	$25.91M	$19.94M
YoY Change	31.37%	29.93%	-17.14%
LONG-TERM ASSETS
Property, Plant & Equipment	$513.0K	$508.0K	$1.218M
YoY Change	-28.75%	-58.29%	90.91%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$262.0K	$268.0K	$390.0K
YoY Change	-20.36%	-31.28%	8.33%
Total Long-Term Assets	$2.804M	$2.557M	$3.283M
YoY Change	-9.4%	-22.11%	38.64%
TOTAL ASSETS
Total Short-Term Assets	$23.61M	$25.91M	$19.94M
Total Long-Term Assets	$2.804M	$2.557M	$3.283M
Total Assets	$26.41M	$28.46M	$23.22M
YoY Change	25.38%	22.57%	-12.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$774.0K	$365.0K	$227.0K
YoY Change	150.49%	60.79%	-53.86%
Accrued Expenses	$1.208M	$943.0K	$839.0K
YoY Change	34.37%	12.4%	-47.99%
Deferred Revenue	$954.0K	$1.304M
YoY Change	-33.1%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.983M	$2.620M	$2.342M
YoY Change	12.31%	11.87%	1.65%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$28.00K	$2.468M	$3.279M
YoY Change	-99.03%	-24.73%	83.29%
Total Long-Term Liabilities	$2.630M	$2.468M	$3.279M
YoY Change	-9.12%	-24.73%	83.29%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.983M	$2.620M	$2.342M
Total Long-Term Liabilities	$2.630M	$2.468M	$3.279M
Total Liabilities	$5.613M	$5.088M	$5.621M
YoY Change	1.14%	-9.48%	37.33%
SHAREHOLDERS EQUITY
Retained Earnings	-$30.30M	-$27.45M
YoY Change	45.3%
Common Stock	$51.12M	$50.82M
YoY Change	40.57%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$20.80M	$23.38M	$17.60M
YoY Change
Total Liabilities & Shareholders Equity	$26.41M	$28.46M	$23.22M
YoY Change	25.38%	22.57%	-12.14%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$2.876M	-$2.686M	-$2.788M
YoY Change	3.75%	-3.66%	73.6%
Depreciation, Depletion And Amortization	$37.00K	$155.0K	$50.00K
YoY Change	-30.19%	210.0%	194.12%
Cash From Operating Activities	-$2.609M	-$2.474M	-$224.0K
YoY Change	20.01%	1004.46%	-71.06%
INVESTING ACTIVITIES
Capital Expenditures	$42.00K	$15.00K	-$24.00K
YoY Change	133.33%	-162.5%	-79.49%
Acquisitions
YoY Change
Other Investing Activities	-$3.500M	-$12.00M
YoY Change	-333.33%
Cash From Investing Activities	-$3.542M	-$12.02M	-$24.00K
YoY Change	-339.0%	49962.5%	-79.49%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$64.00K	$13.98M
YoY Change
NET CHANGE
Cash From Operating Activities	-$2.609M	-$2.474M	-224.0K
Cash From Investing Activities	-$3.542M	-$12.02M	-24.00K
Cash From Financing Activities	-$64.00K	$13.98M
Net Change In Cash	-$6.215M	-$512.0K	$0.00
YoY Change	798.12%		-100.0%
FREE CASH FLOW
Cash From Operating Activities	-$2.609M	-$2.474M	-$224.0K
Capital Expenditures	$42.00K	$15.00K	-$24.00K
Free Cash Flow	-$2.651M	-$2.489M	-$200.0K
YoY Change	20.94%	1144.5%	-69.56%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001577445
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q4	us-gaap	Other Liability Current Related And Nonrelated Party Status Extensible Enumeration OtherLiabilityCurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q1	us-gaap	Other Liability Current Related And Nonrelated Party Status Extensible Enumeration OtherLiabilityCurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
CY2022Q1	SCTC	Severance Pay Asset And Liability SeverancePayAssetAndLiability		usd
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset		usd
CY2022Q1	SCTC	Withdrawal Short Term Deposits WithdrawalShortTermDeposits		usd
CY2022Q1	SCTC	Payments Investment To Short Term Deposits PaymentsInvestmentToShortTermDeposits		usd
CY2022Q1	SCTC	Proceeds From Issuance Of Shares And Warrants ProceedsFromIssuanceOfSharesAndWarrants		usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
CY2022Q1	SCTC	Non Cash Issuance Expenses NonCashIssuanceExpenses		usd
CY2023Q1	SCTC	Contract With Customer Liability Deferred Revenue Relating To New Sales ContractWithCustomerLiabilityDeferredRevenueRelatingToNewSales		usd
CY2023Q1	us-gaap	Other Liability Current Related And Nonrelated Party Status Extensible Enumeration OtherLiabilityCurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q4	us-gaap	Other Liability Current Related And Nonrelated Party Status Extensible Enumeration OtherLiabilityCurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	333-188920
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	SCOUTCAM INC.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-4257143
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	Suite 7A
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Industrial Park
CY2023Q1	dei	Entity Address Address Line3 EntityAddressAddressLine3	P.O. Box 3030
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Omer
CY2023Q1	dei	Entity Address Country EntityAddressCountry	IL
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	8496500
CY2023Q1	dei	City Area Code CityAreaCode	972
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	73 370-4691
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	10432518	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9583000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10099000	usd
CY2023Q1	us-gaap	Deposits Assets Current DepositsAssetsCurrent	15005000	usd
CY2022Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	3047000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	61000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	60000	usd
CY2023Q1	us-gaap	Inventory Gross InventoryGross	693000	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	630000	usd
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	564000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	281000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	25906000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	14117000	usd
CY2023Q1	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	1435000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	1495000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	508000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	648000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	346000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	307000	usd
CY2023Q1	SCTC	Severance Pay Asset SeverancePayAsset	268000	usd
CY2022Q4	SCTC	Severance Pay Asset SeverancePayAsset	328000	usd
CY2023Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	2557000	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	2778000	usd
CY2023Q1	us-gaap	Assets Assets	28463000	usd
CY2022Q4	us-gaap	Assets Assets	16895000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	365000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	297000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1304000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1426000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	195000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	199000	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	352000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	365000	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	8000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	58000	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	396000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	214000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	2620000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2559000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	2112000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	2218000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	94000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	64000	usd
CY2023Q1	SCTC	Liability For Severance Pay LiabilityForSeverancePay	262000	usd
CY2022Q4	SCTC	Liability For Severance Pay LiabilityForSeverancePay	268000	usd
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2468000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2550000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	5088000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	5109000	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10432518	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10432518	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7121737	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7121737	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	10000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	7000	usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	50813000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	36541000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-27448000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-24762000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	23375000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	11786000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	28463000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16895000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	303000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2000	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	550000	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	288000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	-247000	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	-286000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1398000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	954000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	176000	usd
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	243000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	958000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1286000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2779000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2769000	usd
CY2023Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	7000	usd
CY2022Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	8000	usd
CY2023Q1	SCTC	Financing Income Expenses Net FinancingIncomeExpensesNet	86000	usd
CY2022Q1	SCTC	Financing Income Expenses Net FinancingIncomeExpensesNet	-27000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2686000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2788000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.37
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.39
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7276000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7122000	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	11786000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	348000	usd
CY2023Q1	SCTC	Stock Issued During Period Value Of Shares And Warrants StockIssuedDuringPeriodValueOfSharesAndWarrants	13927000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2686000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	23375000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	19616000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	19616000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	772000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2788000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	17600000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	17600000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2686000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2788000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	155000	usd
CY2022Q1	us-gaap	Depreciation Depreciation	50000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	348000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	772000	usd
CY2023Q1	SCTC	Severance Pay Asset And Liability SeverancePayAssetAndLiability	-54000	usd
CY2023Q1	SCTC	Gain Or Loss On Exchange From Operating Lease Liability GainOrLossOnExchangeFromOperatingLeaseLiability	9000	usd
CY2022Q1	SCTC	Gain Or Loss On Exchange From Operating Lease Liability GainOrLossOnExchangeFromOperatingLeaseLiability	10000	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-4000	usd
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-41000	usd
CY2023Q1	SCTC	Interest Income In Respect Of Deposits InterestIncomeInRespectOfDeposits	-42000	usd
CY2022Q1	SCTC	Interest Income In Respect Of Deposits InterestIncomeInRespectOfDeposits	13000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	63000	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	23000	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-48000	usd
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-16000	usd
CY2023Q1	SCTC	Increase Decrease In Right Of Use Asset IncreaseDecreaseInRightOfUseAsset	44000	usd
CY2022Q1	SCTC	Increase Decrease In Right Of Use Asset IncreaseDecreaseInRightOfUseAsset	19000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	283000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-27000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	68000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	124000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	50000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	39000	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-60000	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-228000	usd
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	1616000	usd
CY2023Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-63000	usd
CY2022Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	20000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	182000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	2000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2474000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-224000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	15000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	24000	usd
CY2023Q1	SCTC	Withdrawal Short Term Deposits WithdrawalShortTermDeposits	3000000	usd
CY2023Q1	SCTC	Payments Investment To Short Term Deposits PaymentsInvestmentToShortTermDeposits	15000000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-12015000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-24000	usd
CY2023Q1	SCTC	Proceeds From Issuance Of Shares And Warrants ProceedsFromIssuanceOfSharesAndWarrants	13977000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	13977000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-512000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-248000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	10099000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8581000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-4000	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-41000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	9583000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8292000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	83000	usd
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	46000	usd
CY2023Q1	SCTC	Non Cash Issuance Expenses NonCashIssuanceExpenses	50000	usd
CY2023Q1	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_80C_eus-gaap--NatureOfOperations_zumE0HZgn4gl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 – <span id="xdx_823_zHesyyvHc6I">GENERAL</span>:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>a</b>.</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ScoutCam Inc. (the “Company”), formerly known as Intellisense Solutions Inc., (“Intellisense”), was incorporated under the laws of the State of Nevada on March 22, 2013. Prior to the closing of the Exchange Agreement (as defined below), the Company was a non-operating “shell company”.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s wholly owned subsidiary, ScoutCam Ltd. (“ScoutCam”), was formed in the State of Israel on January 3, 2019, as a wholly-owned subsidiary of Medigus Ltd. (“Medigus”), an Israeli company traded on the Nasdaq Capital Market, and commenced operations on March 1, 2019.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In December 2019, Medigus and ScoutCam consummated an asset transfer agreement, under which Medigus transferred and assigned certain assets and intellectual property rights related to its miniaturized imaging business to ScoutCam.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 30, 2019, Intellisense and Medigus consummated a securities exchange agreement (the “Exchange Agreement”), pursuant to which Medigus delivered 100% of its holdings in ScoutCam to Intellisense in exchange for shares of Intellisense’s common stock representing 60% of the issued and outstanding share capital of Intellisense immediately upon the consummation of the Exchange Agreement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2023, Medigus beneficially owned 18.45% of the Company’s outstanding common stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company, through ScoutCam, is engaged in the development, production and marketing of Predictive Maintenance (PdM) and Condition Based Monitoring (CBM) technologies, providing visual sensing and AI-based video analytics solutions for systems in the aviation, maritime, industrial non-destructing-testing industries, transportation, and energy industries. Some of the Company’s products utilize micro visualization technology in medical devices for minimally invasive medical procedures. </span></p></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SCOUTCAM INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 – GENERAL </b>(continued):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>b</b>.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Since incorporation of ScoutCam and through March 31, 2023, the Company accumulated a deficit of approximately $27.4 million and its activities have been funded mainly by its shareholders. The Company’s management believes the Company’ cash and cash resources will allow the Company to fund its operating plan through at least the next 12 months from the filing date of these Interim Condensed Consolidated Financial Statements. However, the Company expects to continue to incur significant research and development and other costs related to its ongoing operations, requiring the Company to obtain additional funding in order to continue its future operations until becoming profitable.</p> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84C_eus-gaap--UseOfEstimates_zSKjrGRDnta4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>c. </b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_869_zMKgMDNVyNni">Use of estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. The Company evaluates on an ongoing basis its assumptions, including those related to contingencies, deferred taxes, inventory impairment, stock-based compensation, as well as in estimates used in applying the revenue recognition policy. Actual results may differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	346000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	289000	usd
CY2022Q4	us-gaap	Sublease Income SubleaseIncome	3000	usd
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	57000	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	57000	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P0Y10M6D
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.06	pure
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	175000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	85000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	44000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	304000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	15000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	289000	usd
CY2023Q1	us-gaap	Share Price SharePrice	5
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	4.5
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.375	pure
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P7Y
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0394	pure
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1560040	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.64
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	57000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	4.50
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	18512	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	3.37
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1598528	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.68
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	908803	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	3.15
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	348000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	303000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Useful Life PropertyPlantAndEquipmentUsefulLife	P7Y
CY2023Q1	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	1435000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	1495000	usd
CY2023Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	3416000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	3644000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	1495000	usd
CY2021Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	1675000	usd
CY2023Q1	SCTC	Contract With Customer Asset Contract Costs ContractWithCustomerAssetContractCosts	-60000	usd
CY2022	SCTC	Contract With Customer Asset Contract Costs ContractWithCustomerAssetContractCosts	-180000	usd
CY2023Q1	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	1435000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	1495000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	3644000	usd
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2420000	usd
CY2022	SCTC	Contract With Customer Liability Deferred Revenue Relating To New Sales ContractWithCustomerLiabilityDeferredRevenueRelatingToNewSales	1613000	usd
CY2023Q1	SCTC	Contract With Customer Liability Revenue Recognized Development Services ContractWithCustomerLiabilityRevenueRecognizedDevelopmentServices	-228000	usd
CY2022	SCTC	Contract With Customer Liability Revenue Recognized Development Services ContractWithCustomerLiabilityRevenueRecognizedDevelopmentServices	-389000	usd
CY2023Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	3416000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	3644000	usd
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	3400000	usd
CY2023Q1	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	258000	usd
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	438000	usd
CY2023Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	300000	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	148000	usd
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	135000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	44000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	693000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	630000	usd
CY2023Q1	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	8000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	58000	usd
CY2023Q1	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	29000	usd
CY2022Q1	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	25000	usd

Files In Submission

Name	View Source	Status
0001493152-23-015723-index-headers.html	Edgar Link	pending
0001493152-23-015723-index.html	Edgar Link	pending
0001493152-23-015723.txt	Edgar Link	pending
0001493152-23-015723-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sctc-20230331.xsd	Edgar Link	pending
Show.js	Edgar Link	pending
sctc-20230331_def.xml	Edgar Link	unprocessable
sctc-20230331_cal.xml	Edgar Link	unprocessable
sctc-20230331_lab.xml	Edgar Link	unprocessable
sctc-20230331_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ODYS
Odysight.ai Inc. Stock $odys

2023 Q2 Form 10-Q Financial Statement

#000149315223015723 Filed on May 08, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ODYS Odysight.ai Inc. Stock $odys

2023 Q2 Form 10-Q Financial Statement

#000149315223015723 Filed on May 08, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ODYS
Odysight.ai Inc. Stock $odys